Tisento Therapeutics, Inc. announced that it has received $81 million in funding from Cyclerion Therapeutics, Inc., Invus, Polaris, and other investors

Tisento Therapeutics, Inc. announced that it has received $81,000,000 in a round of funding on July 31, 2023. The transaction included participation from new investors, Cyclerion Therapeutics, Inc., Invus, Polaris, individual investor Peter Hecht, and others. The company has issued common shares in the transaction